ROYAL BANK OF CANADA - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$0350.0%0.00%
Q2 2023$0350.0%0.00%
Q1 2023$0350.0%0.00%
Q4 2022$035
-75.0%
0.00%
Q3 2022$0
-100.0%
140
-86.0%
0.00%
Q4 2021$5,000
-37.5%
1,0000.0%0.00%
Q3 2021$8,000
-20.0%
1,0000.0%0.00%
Q2 2021$10,0001,0000.00%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$10,087,97915.03%
Artal Group S.A. 2,255,375$2,0520.09%
Redmile Group, LLC 1,608,089$1,463,2000.07%
Forefront Analytics, LLC 78,169$71,1260.04%
Baker Brothers Advisors 2,557,149$2,326,7500.01%
Point72 Asset Management, L.P. 1,413,809$1,286,4250.00%
XTX Topco Ltd 21,084$19,1840.00%
Coppell Advisory Solutions LLC 1,000$5,5600.00%
Renaissance Technologies 437,528$3980.00%
JPMORGAN CHASE & CO 989$9000.00%
View complete list of ACHILLES THERAPEUTICS PLC shareholders